-
Loading metrics
Open Access
Peer-reviewed
Research Article
Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
-
Stephanie L. Rellick ,
Contributed equally to this work with: Stephanie L. Rellick, Heather O'Leary
Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Heather O'Leary ,
Contributed equally to this work with: Stephanie L. Rellick, Heather O'Leary
Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Debbie Piktel,
Affiliation Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Cheryl Walton,
Affiliation Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
James E. Fortney,
Affiliation Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Stephen M. Akers,
Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Karen H. Martin,
Affiliation Department of Neurobiology and Anatomy, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
James Denvir,
Affiliation Department of Statistics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Goran Boskovic,
Affiliation Microarray Core Facility, Marshall University, Huntington, West Virginia, United States of America
⨯ -
Donald A. Primerano,
Affiliation Microarray Core Facility, Marshall University, Huntington, West Virginia, United States of America
⨯ -
Jeffrey Vos,
Affiliation West Virginia University Department of Pathology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America,
⨯ -
Nathanael Bailey,
Affiliation West Virginia University Department of Pathology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America,
⨯ -
Marieta Gencheva,
Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯ -
Laura F. Gibson
* E-mail: lgibson@hsc.wvu.edu
Affiliations Cancer Cell Biology Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America, Department of Microbiology, Immunology and Cell Biology, School of Medicine, West Virginia University, Morgantown, West Virginia, United States of America
⨯
Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
- Stephanie L. Rellick,
- Heather O'Leary,
- Debbie Piktel,
- Cheryl Walton,
- James E. Fortney,
- Stephen M. Akers,
- Karen H. Martin,
- James Denvir,
- Goran Boskovic,
- Donald A. Primerano
- Published: February 17, 2012
- https://doi.org/10.1371/journal.pone.0030758